BIOMARIN PHARMACEUTICAL
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.
BIOMARIN PHARMACEUTICAL
Industry:
Biotechnology Developer Platform
Founded:
1997-03-01
Address:
San Rafael, California, United States
Country:
United States
Website Url:
http://www.biomarin.com
Total Employee:
1001+
Status:
Active
Contact:
415-506-6700
Email Addresses:
[email protected]
Total Funding:
585.8 M USD
Technology used in webpage:
IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Nginx Amazon IPv6 JsDelivr Microsoft Azure DNS
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-11-24 | Prosensa | Prosensa acquired by BioMarin Pharmaceutical | 840 M USD |
| 2013-01-07 | Zacharon Pharmaceuticals | Zacharon Pharmaceuticals acquired by BioMarin Pharmaceutical | N/A |
| 2010-08-17 | Zystor | Zystor acquired by BioMarin Pharmaceutical | 115 M USD |
| 2010-02-10 | LEAD Therapeutics | LEAD Therapeutics acquired by BioMarin Pharmaceutical | 97 M USD |
| 2009-10-26 | Huxley Pharmaceuticals | Huxley Pharmaceuticals acquired by BioMarin Pharmaceutical | N/A |
| 2002-02-07 | Glyko Biomedical | Glyko Biomedical acquired by BioMarin Pharmaceutical | N/A |
Newest Events participated
Participated in 14th Annual International Pediatric Orthopaedic Symposium
on 2017-11-28 as sponsor
Participated in Abilities Expo Houston 2015
on 2015-07-31 as exhibitor
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-04 | BioMarin snags Vertex VP as CMO a month after clinical snafu in gene therapy trial |
Official Site Inspections
http://www.biomarin.com Semrush global rank: 1.68 M Semrush visits lastest month: 14.5 K
- Host name: 13.107.213.41
- IP address: 13.107.213.41
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioMarin Pharmaceutical"
About Us | BioMarin
BioMarin RareConnections™ Program Established. Expanding on its decade-long track record of supporting eligible people with rare diseases in gaining access to the company’s medicines, the BioMarin RareConnections program …See details»
BioMarin Leadership Team - BioMarin Corporate
BioMarin Leadership Team. Alexander Hardy. President and Chief Executive Officer. G. Eric Davis. Executive Vice President, Chief Legal Officer. Greg Friberg. Executive Vice President, …See details»
BioMarin Pharmaceutical - Wikipedia
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturi…See details»
BioMarin Pharmaceutical Inc. - Governance - Governance
BioMarin - BioCT
BioMarin is a global biotechnology company with eight marketed products that treat life-threatening conditions. Since our founding in 1997, we’ve applied our scientific expertise in …See details»
BioMarin Pharmaceutical - The Org
BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life …See details»
BioMarin Simplifies Organizational Structure to Increase Efficiency
SAN RAFAEL, Calif., Oct. 6, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced its decision to redesign the organization to better focus …See details»
BioMarin, Canada
Géré par le partenaire de BioMarin, Innomar Strategies, BioMarin RareConnections est un service privé, confidentiel et gratuit d’assistance aux personnes auxquelles des médicaments …See details»
About Us - BioMarin Europe & Canada
You are about to leave the BioMarin.eu website and will be redirected to BioMarin’s global website owned and operated by our headquarters, BioMarin Pharmaceutical Inc., located in the United States. Please note that the …See details»
BioMarin Pharmaceutical - Crunchbase Company …
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product …See details»
BioMarin, Canada
BioMarin RareConnections was created to help navigate some of the difficulties associated with serious rare genetic diseases by offering product support services throughout the treatment …See details»
Community | BioMarin
BP has educated over 3,915 youth and made more than 1,564 placements into paid training positions, with student earnings totaling more than $3.4 million. BioMarin has partnered with …See details»
BioMarin Announces Governance Enhancements and Value …
Dec 20, 2023 BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced several initiatives …See details»
BioMarin, having retrenched, outlines plans for growth
Sep 4, 2024 BioMarin aims to bring in $4 billion in revenue by 2027, up from $2.4 billion last year, and maintain an annual growth rate in the mid-teen percentages through the decade, …See details»
BioMarin Pharmaceutical - Contacts, Employees, Board Members, …
BioMarin Pharmaceutical has 23 current employee profiles, including Director, Business Development and Corporate Strategy Chieze Ibeneche-Nnewihe. BioMarin Pharmaceutical …See details»
BioMarin Pharmaceutical Inc - Company Profile - GlobalData
BioMarin Pharmaceutical Inc (BioMarin) is a biotechnology company that develops and commercializes innovative medicines for the treatment of rare genetic diseases and medical …See details»
BioMarin Simplifies Organizational Structure to Increase Efficiency
SAN RAFAEL, Calif., Oct. 6, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced its decision to redesign the organization to better focus …See details»
BioMarin Pharmaceutical Inc. | Europe & Canada
You are about to leave the BioMarin.eu website and will be redirected to BioMarin’s global website owned and operated by our headquarters, BioMarin Pharmaceutical Inc., located in the United …See details»
Mission, Vision & Core Values of BioMarin Pharmaceutical
Dec 19, 2024 [cbm_blg_rlnkng]BioMarin Pharmaceutical is a leading biotechnology company dedicated to developing innovative therapies for rare genetic diseases. With a mission to …See details»
BioMarin Pharmaceutical Mission, Benefits, and Work Culture
Come see what’s going on inside BioMarin Pharmaceutical, including the company culture, employee work-life benefits, and business goals. Discover all the key insights that make …See details»